Literature DB >> 21044778

Dependence as a unifying construct in defining Alzheimer's disease severity.

Trent McLaughlin1, Howard Feldman, Howard Fillit, Mary Sano, Frederick Schmitt, Paul Aisen, Christopher Leibman, Lisa Mucha, J Michael Ryan, Sean D Sullivan, D Eldon Spackman, Peter J Neumann, Joshua Cohen, Yaakov Stern.   

Abstract

This article reviews measures of Alzheimer's disease (AD) progression in relation to patient dependence and offers a unifying conceptual framework for dependence in AD. Clinicians typically characterize AD by symptomatic impairments in three domains: cognition, function, and behavior. From a patient's perspective, changes in these domains, individually and in concert, ultimately lead to increased dependence and loss of autonomy. Examples of dependence in AD range from a need for reminders (early AD) to requiring safety supervision and assistance with basic functions (late AD). Published literature has focused on the clinical domains as somewhat separate constructs and has given limited attention to the concept of patient dependence as a descriptor of AD progression. This article presents the concept of dependence on others for care needs as a potential method for translating the effect of changes in cognition, function, and behavior into a more holistic, transparent description of AD progression.
Copyright © 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21044778      PMCID: PMC3884683          DOI: 10.1016/j.jalz.2009.09.004

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  40 in total

Review 1.  Management of severe Alzheimer's disease and end-of-life issues.

Authors:  L Volicer
Journal:  Clin Geriatr Med       Date:  2001-05       Impact factor: 3.076

2.  Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease.

Authors:  Colin Green; Joanna Picot; Emma Loveman; Andrea Takeda; Jo Kirby; Andrew Clegg
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

3.  Temporal quantification of Alzheimer's disease severity: 'time index' model.

Authors:  J W Ashford; M Shan; S Butler; A Rajasekar; F A Schmitt
Journal:  Dementia       Date:  1995 Sep-Oct

4.  Relatives of the impaired elderly: correlates of feelings of burden.

Authors:  S H Zarit; K E Reever; J Bach-Peterson
Journal:  Gerontologist       Date:  1980-12

5.  Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.

Authors:  R A Mulnard; C W Cotman; C Kawas; C H van Dyck; M Sano; R Doody; E Koss; E Pfeiffer; S Jin; A Gamst; M Grundman; R Thomas; L J Thal
Journal:  JAMA       Date:  2000-02-23       Impact factor: 56.272

6.  Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.

Authors:  Pierre N Tariot; Martin R Farlow; George T Grossberg; Stephen M Graham; Scott McDonald; Ivan Gergel
Journal:  JAMA       Date:  2004-01-21       Impact factor: 56.272

7.  A dependency model for patients with Alzheimer's disease: its validation and relationship to the costs of care--the LASER-AD Study.

Authors:  G Livingston; C Katona; B Roch; C Guilhaume; B Rive
Journal:  Curr Med Res Opin       Date:  2004-07       Impact factor: 2.580

8.  Caregivers' assessments of preference-based quality of life in Alzheimer's disease.

Authors:  Jason H Karlawish; Art Zbrozek; Bruce Kinosian; Annemarie Gregory; Allison Ferguson; Dominique V Low; Henry A Glick
Journal:  Alzheimers Dement       Date:  2008-04-24       Impact factor: 21.566

9.  Alzheimer disease in the US population: prevalence estimates using the 2000 census.

Authors:  Liesi E Hebert; Paul A Scherr; Julia L Bienias; David A Bennett; Denis A Evans
Journal:  Arch Neurol       Date:  2003-08

10.  The rate of cognitive decline and risk of reaching clinical milestones in Alzheimer disease.

Authors:  Roee Holtzer; Domonick J Wegesin; Steven M Albert; Karen Marder; Karen Bell; Marilyn Albert; Jason Brandt; Yaakov Stern
Journal:  Arch Neurol       Date:  2003-08
View more
  18 in total

1.  Malnutrition in care home residents with dementia.

Authors:  J M M Meijers; J M G A Schols; R J G Halfens
Journal:  J Nutr Health Aging       Date:  2014       Impact factor: 4.075

Review 2.  Periodontal Systemic Connections-Novel Associations-A Review of the Evidence with Implications for Medical Practitioners.

Authors:  Butchibabu Kalakonda; Pradeep Koppolu; Kusai Baroudi; Ashank Mishra
Journal:  Int J Health Sci (Qassim)       Date:  2016-04

3.  Dependence Stage and Pharmacoeconomic Outcomes in Patients With Alzheimer Disease.

Authors:  Tzeyu L Michaud; Robin High; Mary E Charlton; Daniel L Murman
Journal:  Alzheimer Dis Assoc Disord       Date:  2017 Jul-Sep       Impact factor: 2.703

4.  Association between illness progression measures and total cost in Alzheimer's disease.

Authors:  L A Lacey; T Niecko; C Leibman; E Liu; M Grundman
Journal:  J Nutr Health Aging       Date:  2013-09       Impact factor: 4.075

Review 5.  Health state values for use in the economic evaluation of treatments for Alzheimer's disease.

Authors:  James Shearer; Colin Green; Craig W Ritchie; John P Zajicek
Journal:  Drugs Aging       Date:  2012-01-01       Impact factor: 3.923

Review 6.  The use of formal care for dementia from a professional perspective: a scoping review.

Authors:  Stefanie Bergmann; Julia Peper; Anja Bieber
Journal:  BMC Health Serv Res       Date:  2022-06-25       Impact factor: 2.908

7.  The validity of dependence as a health outcome measure in Alzheimer's disease.

Authors:  D Eldon Spackman; Srikanth Kadiyala; Peter J Neumann; David L Veenstra; Sean D Sullivan
Journal:  Am J Alzheimers Dis Other Demen       Date:  2013-03-19       Impact factor: 2.035

8.  Dependence Clusters in Alzheimer Disease and Medicare Expenditures: A Longitudinal Analysis From the Predictors Study.

Authors:  Carolyn W Zhu; Seonjoo Lee; Katherine A Ornstein; Stephanie Cosentino; Yian Gu; Howard Andrews; Yaakov Stern
Journal:  Alzheimer Dis Assoc Disord       Date:  2020 Oct-Dec       Impact factor: 2.357

Review 9.  Novel strategies for Alzheimer's disease treatment: An overview of anti-amyloid beta monoclonal antibodies.

Authors:  Katarzyna Rygiel
Journal:  Indian J Pharmacol       Date:  2016 Nov-Dec       Impact factor: 1.200

10.  Relationship between care dependency and behavioral symptoms among elderly in-patients with Alzheimer's disease in Japan and the Netherlands.

Authors:  Ate Dijkstra; Mizue Suzuki; Hetty Kazimier; Miyuki Fujiwara; Tomohiro Saegusa
Journal:  SAGE Open Med       Date:  2015-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.